GSK plc · LSE:GSK
GSK — GSK Consumer Healthcare Pakistan — Corporate Update (2019)
31 slides from GSK's corporate update, 2019
Slide 1: Corporate Briefing Session
Corporate Briefing Session GSK Consumer Healthcare Pakistan Limited
Slide 2: Agenda
Agenda Company Brief Our Vision, Values and Strategy Strategic / Operational developments Financial Details Questions and Answers 2
Slide 3: Company Brief
Company Brief
Slide 4: Company History
Company History GSK Consumer GSK Consumer GSK Consumer GSK OTC Private 2015 2016 2017 2018 business Healthcare Healthcare Pakistan Limited merged with demerged from Pakistan Limited Limited got listed on GSK Consumer GSK Pakistan starts operations Pakistan Stock Healthcare Pakistan Limited. as an in
Slide 5: Our Local Footprint
Our Local Footprint Registered Office: 35-Dockyard Road, West Wharf, Karachi Sales Offices: Karachi – B 63, 65, Estate Avenue, SITE Lahore – 880 B, Faisal Town Islamabad – Aleem House, Plot 409, Sector I9, West Wharf Office Industrial Area Factory: • GSK CHC acquired the manufacturing facility of GS
Slide 6: Board Committees & Key Roles
Board Committees & Key Roles Human Resource Integration Supply & Management Audit Committee and Remuneration Network Optimization Committee Committee Committee • M.Z. Moin Mohajir • Syed Anwar • Emine Tasci Kaya • Sohail Matin (Chairman) Mahmood (Chairperson) • Talal Javed Ahmed • Syed Anwar (Chairm
Slide 7: Our Vision, Values, Strategy and Portfolio
Our Vision, Values, Strategy and Portfolio
Slide 8: BY THE TI
BY THE TI FINISH WATCHIN THIS VIDEO
Slide 9: Our Purpose, Goal and Strategy
Our Purpose, Goal and Strategy Purpose To help people do more, feel better, live longer Goal To be one of the world’s most innovative, best performing and trusted consumer healthcare companies Strategy Innovation Performance Trust • Brilliant execution of Sustained industry-leading • Reliable supply
Slide 10: Customer First
Our Values & Expectations are at the Heart of Everything We Do Customer First 10
Slide 11: Brands Portfolio
Brands Portfolio FMCG OVER THE COUNTER (Regulated by DRAP) (Represents 20% business) (Represents 80% business) Oral Care Skin Health Nutrition Nutrition & Skin Health Respiratory Pain Relief Digestive 11
Slide 12: Key Brands: Top 3 Brands Contributing 66% to Total Business
Key Brands Top 3 Brands Contributing 66 % to Total Cx Business… With 15% Value Growth & 12% Volume Growth Prescribed Calcium in Pain Relief Category in Sensitivity Category supplement 33.6% Contribution 13.4% Contribution 18.9% Contribution GSK Share 16.5% GSK Share 13% GSK Share 36% 11.6% Volume Gr
Slide 13: Innovations
Innovations Oral Care Pain Relief Nutrition
Slide 14: Strategic / Operational developments
Strategic / Operational developments
Slide 15: Route to Market
Route to Market Total Distributors 46 FMCG Total Universe 271 K (20%) ISLAMABAD FMCG 55.000 DC Outlets FMCG Universe 240 K OTC 36.000 DC Outlets OTC Universe 36 K LAHORE TRADE CHANNELS Retail Chains Mass Market * Pharmacy MULTAN Total Contribution % 11% 25% 64% • FMCG % 69% 47% 5% Region • OTC % 31%
Slide 16: Strategic / Operational developments
Strategic / Operational developments Global Joint Venture Ex-Novartis Consumer SAP deployment between GSK Consumer portfolio merged with GSK completed in Healthcare and Pfizer Consumer Healthcare manufacturing division Consumer Healthcare Pakistan Ltd 16
Slide 17: Financial Details
Financial Details
Slide 18: Balance Sheet
Balance Sheet Net Assets Funded by Fixed Assets Equity Inventories Debt Trade Debts & 8 8 Trade advances billion billion payables Tax refundables Others Others
Slide 19: Revenue Distribution
Revenue Distribution To Employees To Shareholders 7% 4% Retained in the business To Governement 3% 7% Administrative expenses & Financial charges 3% Selling,marketing & distribution expenses 13% Bought-in-material and services 63% 4x3 core presentation Insert your date / confidentiality text here 19
Slide 20: Sales
Sales Amounts in PKR million Quarter 2 Half Year Sales Mix by portfolio 2019 2018 Growth 2019 2018 Growth 12% 4% OTC 1,415 1,203 17.23% 3,184 2,949 7.9% Portfolio 40% FMCG Portfolio 678 602 12.5% 1,269 1,198 5.9% 28% 16% Ex-Novartis 1,265 947 33.5% 2,186 1,784 22.6% Portfolio OTC Portfolio Exports 1
Slide 21: Performance over time
Performance over time 40% 35% H1 2018 30% FY 2018 25% H1 2019 20% 15% 10% 5% 0% Gross Margin SG&A Profit before tax of sales Profit after tax of sales 4x3 core presentation Insert your date / confidentiality text here 21
Slide 22: Key Performance Ratios
Key Performance Ratios Balance Sheet Ratios June 30, 2019 December 31, 2018 Return on equity 22.6% 17.4% Current Ratio 1.31 1.29 Quick Ratio 0.53 0.74 Inventory days 90 74 Receivables days 18 17 Payable days 27 26 22
Slide 23: Thank You
Thank You
Slide 24: Backup slides
Backup slides
Slide 25: Economic indicators
Economic indicators 16x9 core template Insert your date / confidentiality text here 25
Slide 26: Opex Overview
Opex Overview Meetings & travel Promotion (non-detailing) 4% Depreciation of business assets 16% Logistics Cross charges from Pharma 12% 2% Misc Security Insurance Publications Other Repairs and 2% Maintenance Advertising Professional fees 35% IT Assets/Services Resource cost 29% 16x9 core template
Slide 27: Cash Flow Statement
Cash Flow Statement Amounts in PKR million June 30, 2018 June 30, 2019 (Restated) Profit before taxation 841 711 Adjustments for non-cash charges and other items 256 220 Profit before working capital changes 1,097 931 Effect on cash flow due to working capital changes (307) (616) Cash generated from
Slide 28: Balance Sheet
Balance Sheet Amounts in PKR million June 30, 2019 Dec 31, 2018 Variance Percentage Property, Plant and Equipment 2,676 2,650 26 1.0% Intangible 128 128 0 0% Non-current Assets Long-term loans to employees 11 7 3 47.0% Long term deposits 6 3 2 65.5% Stores and spares 55 48 7 14.8% Inventories 3,063
Slide 29: Profit & Loss Statement
Profit & Loss Statement Amounts in PKR million Q2 2019 Q2 2018 Variance H1 2019 H1 2018 Variance (Restated) % (Restated) % Net sales 4,026 3,290 22.4% 7,899 6,918 14.2% Cost of sales (2,511) (2,219) 13.2% (5,311) (4,649) 14.2% Gross Profit 1,514 1,071 41.4% 2,588 2,269 14.1% Gross Profit % 37.6% 32.
Slide 30: Market Vs GSKCH: Month
Market Vs GSKCH: 6 Month KSE 100 GSK CH 4x3 core presentation Insert your date / confidentiality text here 30
Slide 31: Market Vs GSKCH: Month
Market Vs GSKCH : 1 Month KSE 100 GSK CH 4x3 core presentation Insert your date / confidentiality text here 31
GSK Consumer Healthcare Pakistan — Corporate Update (2019) on 6ix